300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Canada
Mongolia
United Kingdom
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Michael Fainshtein, CEO at Mircod

Michael Fainshtein

CEO @ Mircod

Michael Fainshtein is a seed investor at Mircod focused on Sensor and Robotics. Michael Fainshtein

Total investments:
2
Last investment:
Lead investor:
50%

Last updated:

Industries Michael Fainshtein invests in

SensorRoboticsSoftwareHealth CareBiotechnology

Stages Michael Fainshtein invests in

Seed

Countries Michael Fainshtein invests in

United States

Round sizes

Seed $700k–$1.3M

Round size

Seed
$700k–$1.3M

Investment Focus

Industry

  • Sensor 1 (50%)
  • Robotics 1 (50%)
  • Software 1 (50%)
  • Health Care 1 (50%)
  • Biotechnology 1 (50%)
See all 10 industries →

Investments

CompanyDescriptionRoundLinks
Mircod Mircod
IoT and IoMT (Healthcare IoT) creation require ever-increasing and sophisticated electronic design. It also demands a superior level of expertise and necessitates the need for experienced and highly professional companies to expedite the development process. At the core of every electronic product is the electronics (hardware) and firmware(software) needed to run it.Mircod experience and multi-disciplines enable the company to provide turnkey development of: • Circuit Schematics: Analog & Digital, Gerber Artwork, and Layout Design. • Embedded Systems. • Firmware & Micro Controller Programming Software Design. • User-Interface Development. • Hardware Design for CE, FCE, UL, ROHS, WEEE, and FDA.The ability to provide the right, properly “up and running” comprehensive prototype for the desired idea, while selecting the precise components, defines all aspects of a product's performance, realistic proof of concept, durability, cost, and successful market penetration.MIRCOD brings together personnel with substantive expertise in all primary disciplines required to deliver the most complicated hardware and software solutions. This flexible and multi-skilled team brings an inherent understanding of the R&D in hardware and software related activities and the interfaces with other system delivery disciplines (mathematical algorithms, system engineering, sourcing, advanced materials, and manufacturing) required for success. MIRCOD also has the advantage of having worked on a diverse range of activities across a varied customer base in both production and prototyping capacities.BIOTECHNOLOGY Industry - MIRCOD actively participates in R&D projects initiated by international consortiums. Gene therapy technology developed in consideration with international top cell and gene biotech companies and universities, guarantees to transform tomorrow's medicine by treating the causes of disease rather than the manifestations.IoT Industry - We make the Internet of Things easy from Sketch to Scale. MIRCOD white-labeled rapid IoT web-based platform for rapid design, prototyping, design, and manufacturing is a hardware and software-agnostic system with white-label mobile apps, private BA and BI, complete device management, custom-defined analytics, and advanced AI.ROBOTICS Industry - MIRCOD AI-enabled robots are designed to work with scientists on a daily basis in a high demanding space at biotech laboratories. The MIRCOD autonomous robotic arms can be left alone to perform time-consuming biotechnological tasks in R&D biotech labs like setting up comprehensive predefined experiments in POC stations.HEALTHCARE Industry - MIRCOD team believes that today's remote monitoring technology isn't sufficiently advanced to predict a potential adverse event and alert a monitoring provider before disaster strikes. Our mission is to enhance these technologies and bring to the market an “ease of use” remote monitoring technology platform that enables continuous, configurable, wireless acquiring of biometric parameters from the human body. (Wherefore platform is not limited only to healthcare!) $700K / Seed / Jan 01, 2018
Mircod Mircod
IoT and IoMT (Healthcare IoT) creation require ever-increasing and sophisticated electronic design. It also demands a superior level of expertise and necessitates the need for experienced and highly professional companies to expedite the development process. At the core of every electronic product is the electronics (hardware) and firmware(software) needed to run it.Mircod experience and multi-disciplines enable the company to provide turnkey development of: • Circuit Schematics: Analog & Digital, Gerber Artwork, and Layout Design. • Embedded Systems. • Firmware & Micro Controller Programming Software Design. • User-Interface Development. • Hardware Design for CE, FCE, UL, ROHS, WEEE, and FDA.The ability to provide the right, properly “up and running” comprehensive prototype for the desired idea, while selecting the precise components, defines all aspects of a product's performance, realistic proof of concept, durability, cost, and successful market penetration.MIRCOD brings together personnel with substantive expertise in all primary disciplines required to deliver the most complicated hardware and software solutions. This flexible and multi-skilled team brings an inherent understanding of the R&D in hardware and software related activities and the interfaces with other system delivery disciplines (mathematical algorithms, system engineering, sourcing, advanced materials, and manufacturing) required for success. MIRCOD also has the advantage of having worked on a diverse range of activities across a varied customer base in both production and prototyping capacities.BIOTECHNOLOGY Industry - MIRCOD actively participates in R&D projects initiated by international consortiums. Gene therapy technology developed in consideration with international top cell and gene biotech companies and universities, guarantees to transform tomorrow's medicine by treating the causes of disease rather than the manifestations.IoT Industry - We make the Internet of Things easy from Sketch to Scale. MIRCOD white-labeled rapid IoT web-based platform for rapid design, prototyping, design, and manufacturing is a hardware and software-agnostic system with white-label mobile apps, private BA and BI, complete device management, custom-defined analytics, and advanced AI.ROBOTICS Industry - MIRCOD AI-enabled robots are designed to work with scientists on a daily basis in a high demanding space at biotech laboratories. The MIRCOD autonomous robotic arms can be left alone to perform time-consuming biotechnological tasks in R&D biotech labs like setting up comprehensive predefined experiments in POC stations.HEALTHCARE Industry - MIRCOD team believes that today's remote monitoring technology isn't sufficiently advanced to predict a potential adverse event and alert a monitoring provider before disaster strikes. Our mission is to enhance these technologies and bring to the market an “ease of use” remote monitoring technology platform that enables continuous, configurable, wireless acquiring of biometric parameters from the human body. (Wherefore platform is not limited only to healthcare!) $1.3M / Seed / Dec 01, 2015
Mircod

About Mircod

VC Fund · Boca Raton, United States

IoT and IoMT (Healthcare IoT) creation require ever-increasing and sophisticated electronic design. It also demands a superior level of expertise and necessitates the need for experienced and highly professional companies to expedite the development process. At the core of every electronic product is the electronics (hardware) and firmware(software) needed to run it.Mircod experience and multi-disciplines enable the company to provide turnkey development of: • Circuit Schematics: Analog & Digital, Gerber Artwork, and Layout Design. • Embedded Systems. • Firmware & Micro Controller Programming Software Design. • User-Interface Development. • Hardware Design for CE, FCE, UL, ROHS, WEEE, and FDA.The ability to provide the right, properly “up and running” comprehensive prototype for the desired idea, while selecting the precise components, defines all aspects of a product's performance, realistic proof of concept, durability, cost, and successful market penetration.MIRCOD brings together personnel with substantive expertise in all primary disciplines required to deliver the most complicated hardware and software solutions. This flexible and multi-skilled team brings an inherent understanding of the R&D in hardware and software related activities and the interfaces with other system delivery disciplines (mathematical algorithms, system engineering, sourcing, advanced materials, and manufacturing) required for success. MIRCOD also has the advantage of having worked on a diverse range of activities across a varied customer base in both production and prototyping capacities.BIOTECHNOLOGY Industry - MIRCOD actively participates in R&D projects initiated by international consortiums. Gene therapy technology developed in consideration with international top cell and gene biotech companies and universities, guarantees to transform tomorrow's medicine by treating the causes of disease rather than the manifestations.IoT Industry - We make the Internet of Things easy from Sketch to Scale. MIRCOD white-labeled rapid IoT web-based platform for rapid design, prototyping, design, and manufacturing is a hardware and software-agnostic system with white-label mobile apps, private BA and BI, complete device management, custom-defined analytics, and advanced AI.ROBOTICS Industry - MIRCOD AI-enabled robots are designed to work with scientists on a daily basis in a high demanding space at biotech laboratories. The MIRCOD autonomous robotic arms can be left alone to perform time-consuming biotechnological tasks in R&D biotech labs like setting up comprehensive predefined experiments in POC stations.HEALTHCARE Industry - MIRCOD team believes that today's remote monitoring technology isn't sufficiently advanced to predict a potential adverse event and alert a monitoring provider before disaster strikes. Our mission is to enhance these technologies and bring to the market an “ease of use” remote monitoring technology platform that enables continuous, configurable, wireless acquiring of biometric parameters from the human body. (Wherefore platform is not limited only to healthcare!)

Mircod Contacts

NameEmailPhoneSocials
Elvira Fainshtein
Elvira Fainshtein Co-Founder, Ph.D. Medicine, Medical Scientist
Kirill Igin
Kirill Igin V.P. Business Development
Michael Fainshtein
Michael Fainshtein Founder, Director
Ramil Teregulov
Ramil Teregulov CTO

Sign up to unlock verified contacts

Unlock Contacts

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Canada
Mongolia
United Kingdom
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Michael Fainshtein invest in?

Michael Fainshtein invests primarily in Sensor, Robotics and Software startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Michael Fainshtein's check size?

Michael Fainshtein typically joins rounds of $700k–$1.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Michael Fainshtein participates in.

When did Michael Fainshtein last invest?

The most recent investment recorded for Michael Fainshtein closed in Jan 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Michael Fainshtein Michael Fainshtein Find email